For every extra 300 milligrams of dietary cholesterol consumed daily—about the amount in two large eggs—adults in the United States have a 17% higher chance of developing cardiovascular disease over decades, even after accounting for other health behaviors and conditions.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review and meta-analysis of high-quality prospective cohort studies across diverse populations would establish whether the association between dietary cholesterol and CVD is consistent, dose-dependent, and generalizable beyond the US context.
A systematic review and meta-analysis of at least 20 prospective cohort studies from multiple countries, each with validated dietary assessments, 10+ years of follow-up, and adjustment for saturated fat, animal protein, and overall diet quality. Primary outcome: incident CVD events. Population: adults aged 40–75 with no baseline CVD. Exposure: dietary cholesterol intake measured by repeated food frequency questionnaires.
A long-term randomized trial could determine whether reducing dietary cholesterol intake directly reduces CVD events, isolating its effect from other dietary components.
A double-blind, placebo-controlled trial of 5,000 adults aged 45–75 with no CVD, randomized to consume a diet providing 100 mg/day of dietary cholesterol (via cholesterol-free foods and supplements) versus 400 mg/day (via egg yolks and animal products) for 10 years, with primary outcome of composite CVD events (MI, stroke, heart failure, CVD death). All participants receive identical caloric intake, saturated fat levels, and lifestyle counseling.
A prospective cohort study with repeated dietary measurements and rigorous adjudication of CVD events could confirm the dose-response relationship and assess whether the association varies by metabolic health status.
A prospective cohort of 10,000 US adults aged 40–70, with dietary cholesterol intake measured annually via validated food frequency questionnaires and biomarkers (e.g., plasma cholesterol), followed for 20 years with centralized adjudication of CVD events, adjusting for repeated measures of BMI, lipids, blood pressure, and physical activity.
A case-control study could compare past dietary cholesterol intake in individuals with and without CVD to assess whether higher intake is more common among those who developed disease.
A matched case-control study of 2,000 adults with incident CVD (cases) and 2,000 without (controls), matched for age, sex, and race, with detailed dietary recall for the 5 years prior to CVD diagnosis, controlling for smoking, physical activity, and socioeconomic status.
A cross-sectional study could show whether higher dietary cholesterol intake correlates with existing CVD markers like arterial plaque or LDL levels at a single point in time.
A cross-sectional analysis of 5,000 adults aged 45–75 measuring dietary cholesterol intake via 24-hour recall and correlating it with carotid intima-media thickness and serum LDL cholesterol levels, adjusting for age, sex, and BMI.